Charles Schwab’s Oric Pharmaceuticals ORIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.67M Sell
605,037
-16,049
-3% -$182K ﹤0.01% 2219
2025
Q4
$5.08M Buy
621,086
+17,879
+3% +$206K ﹤0.01% 2449
2025
Q3
$7.24M Buy
603,207
+220,818
+58% +$2.32M ﹤0.01% 2273
2025
Q2
$3.88M Sell
382,389
-26,116
-6% -$175K ﹤0.01% 2435
2025
Q1
$2.28M Sell
408,505
-9,450
-2% -$82.6K ﹤0.01% 2567
2024
Q4
$3.37M Buy
417,955
+7,726
+2% +$70.9K ﹤0.01% 2518
2024
Q3
$4.2M Buy
410,229
+247,863
+153% +$2.45M ﹤0.01% 2458
2024
Q2
$1.15M Buy
162,366
+57,822
+55% +$518K ﹤0.01% 2878
2024
Q1
$1.44M Sell
104,544
-2,057
-2% -$24.4K ﹤0.01% 2686
2023
Q4
$981K Buy
106,601
+719
+0.7% +$5.2K ﹤0.01% 2841
2023
Q3
$641K Hold
105,882
﹤0.01% 2954
2023
Q2
$822K Buy
105,882
+89,229
+536% +$507K ﹤0.01% 2832
2023
Q1
$94.9K Hold
16,653
﹤0.01% 3256
2022
Q4
$98.1K Hold
16,653
﹤0.01% 3263
2022
Q3
$54K Sell
16,653
-127,664
-88% -$511K ﹤0.01% 3316
2022
Q2
$647K Sell
144,317
-71,196
-33% -$284K ﹤0.01% 2966
2022
Q1
$1.15M Sell
215,513
-8,918
-4% -$80.3K ﹤0.01% 2799
2021
Q4
$3.3M Buy
224,431
+4,776
+2% +$74.5K ﹤0.01% 2548
2021
Q3
$4.59M Buy
219,655
+88,840
+68% +$1.8M ﹤0.01% 2417
2021
Q2
$2.31M Buy
130,815
+16,312
+14% +$357K ﹤0.01% 2666
2021
Q1
$2.81M Buy
114,503
+4,790
+4% +$151K ﹤0.01% 2551
2020
Q4
$3.71M Buy
109,713
+56,837
+107% +$1.63M ﹤0.01% 2361
2020
Q3
$1.32M Sell
52,876
-846
-2% -$20.1K ﹤0.01% 2617
2020
Q2
$1.81M Buy
+53,722
New +$1.71M ﹤0.01% 2459

Other funds holding ORIC